Trial intelligence / Profile preview

Food Effect on Urate PK of Inosine in Healthy Males

NCT02614469Phase 1Completed

Start
Mar 2015
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of inosine in Parkinson's disease (PD) (2 arms). Primary endpoints: Maximum Observed Serum Urate Concentration, Area Under the Serum Concentration-time Curve From Time 0 to Time t and 4 more. Started Mar 2015; status: completed.

02

Drugs

inosine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT02614469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02614469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call